Fig. 3.
(A) Changes of heart rate, (B) systolic blood pressure, and (C) diastolic blood pressure in spontaneously hypertensive rats (SHRs) treated with fine root concentrate (FR) and hypotensive component-enriched fraction of red ginseng (HCEF-RG) for 8 wk (SHR-control, ▵; FR500, ○; FR1,000, ●; HCEF-RG500, □; HCEF-RG1,000, ■). Wistar Kyoto (WKY)-control (normal control): WKY provided with sterile distilled water; SHR-control (hypertension control): SHR provided with sterile distilled water; FR groups (hypertension and FR treatment): SHR orally provided with fine root concentrations (500 mg/kg, 1,000 mg/kg body weight); HCEF-RG groups (hypertension and HCEF-RG treatment): SHR orally provided with hypotensive components-enriched fraction of red ginseng (500 mg/kg, 1,000 mg/kg body weight). Data are expressed as mean ± SD, n = 8. *p < 0.05 compared with SHR-control.